GA-map® MHI GutHealth
Gut microbiome health assessment (Research Use)
CommercialRUO Launch
Key Facts
Indication
Gut microbiome health assessment (Research Use)
Phase
Commercial
Status
RUO Launch
Company
About Genetic Analysis
Genetic Analysis AS is a diagnostic company focused on unlocking the potential of the human microbiome through its proprietary GA-map® technology platform. A key achievement is the commercialization of the world's first CE-marked IVD test for gut dysbiosis in IBS and IBD, which has been used in over 50 clinical trials. The company is strategically expanding its product portfolio with research-use assays like the MHI GutHealth test, developed with Ferring Pharmaceuticals, and pursuing opportunities in companion diagnostics to support pharmaceutical development.
View full company profile